UPDATE : Friday, July 3, 2020
상단여백
Whistleblowers, shareholders furious over Medytox’s rebuttal by Jeong Sae-im 2020-04-21 15:19
ImmuneMed confident of drug candidate’s effect on Covid-19 by Jeong Sae-im 2020-04-21 13:23
Medytox files suit to cancel administrative order by Shim Hyun-tai 2020-04-20 16:37
DM Bio signs CDMO contract with Abion for antibody treatment by Shim Hyun-tai 2020-04-17 16:03
Medytox CEO charged with making, selling botulinum toxin illegally by Jeong Sae-im 2020-04-17 16:00
라인
Researchers to test asthma drug to treat Covid-19 by Kim Yun-mi 2020-04-16 16:20
Bukwang to test its antiviral drug against Covid-19 by Jeong Sae-im 2020-04-16 12:20
Opdivo’s indication expanded to esophageal squamous cell carcinoma by Kim Yun-mi 2020-04-16 10:48
Pasteur, Daewoong to co-develop COVID-19 drug from parasiticide by Shim Hyun-tai 2020-04-14 17:49
Gilead revised clinical design of potential COVID-19 drug remdesivir. Why? by Kim Yun-mi 2020-04-10 15:36
라인
Executive salaries highest at Samsung Biologics, Celltrion by Jeong Sae-im 2020-04-09 11:13
Review of cancer drug benefits delayed amid social distancing by Kim Yun-mi 2020-04-08 13:46
Jeil’s oral cancer treatment wins extended indication for NSCLC by Shim Hyun-tai 2020-04-06 15:33
Pfizer, MSD put off reorganizing due to COVID-19 by Kim Yun-mi 2020-04-03 17:09
GC Pharma to supply plasma treatment for COVID-19 this year by Shim Hyun-tai 2020-04-02 18:11
라인
Genexine to release results of using Hyleukin-7 & Keytruda at ASCO by Shim Hyun-tai 2020-04-02 17:01
AptaBio wins patent for blood cancer therapy by Shim Hyun-tai 2020-04-02 16:17
Venclexta extended survival in first-line acute myeloid leukemia by Kim Yoon-mi 2020-04-02 15:31
‘More public-private partnership needed to spur research of less-profitable areas’ by You Ji-young 2020-04-01 18:58
GC partner applies for permit of Hunterase ICV to Japan by Shim Hyun-tai 2020-04-01 18:47
여백
여백
여백
Back to Top